Amanote Research
Register
Sign In
Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-10-1095
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 10, 2010
Authors
Y. Guo
J. Nemeth
C. O'Brien
M. Susa
X. Liu
Z. Zhang
E. Choy
H. Mankin
F. Hornicek
Z. Duan
Publisher
American Association for Cancer Research (AACR)
Related search
Hedgehog Signaling Pathway in Ovarian Cancer
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
IL-6 Mediated JAK/STAT3 Signaling Pathway in Cancer Patients With Cachexia
Bratislava Medical Journal
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
IL-6 and Ovarian Cancer--Response
Clinical Cancer Research
Cancer Research
Oncology
IL-6 Inhibits Starvation-Induced Autophagy via the STAT3/Bcl-2 Signaling Pathway
Scientific Reports
Multidisciplinary
Targeting the AXL Signaling Pathway in Ovarian Cancer
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Matrine Increases the Inhibitory Effects of Afatinib on H1975 Cells via the IL-6/JAK1/STAT3 Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Cancer-Associated Fibroblasts Enhance Metastatic Potential of Lung Cancer Cells Through IL-6/STAT3 Signaling Pathway
Oncotarget
Oncology
Figure 6: Effects of Herbs on LPS-induced PGE2, IL-6, and IL-8 Production.